Epidioloex decision PBAC

Epidyolex decision PBAC

TGA Defers Decision to Pay for EpidyolexThe Pharmaceutical Benefits Advisory Committee (PBAC), the body that decides whether Australians can have certain medicines subsidised by the taxpayer,  has announced that it will not – for now – subsidize Epidyolex. Epidyolex is a medicinal cannabis product manufactured by UK cannabis giant GW Pharmaceuticals and containing the active...
Read More